Navigation Links
New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need
Date:11/20/2007

WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- The following statement was released today by Pamela W. Barnes, President and Chief Executive Officer of the Elizabeth Glaser Pediatric AIDS Foundation:

"Four years after the President's Emergency Plan for AIDS Relief (PEPFAR) began funding treatment and prevention, today's report from UNAIDS offers some good news -- while HIV/AIDS remains a devastating worldwide pandemic, we are beginning to make progress. We are especially pleased that the report shows that the estimated number of new infections among children declined from 460,000 in 2001 to 420,000 in 2007, and that HIV declined in pregnant women age 15 to 24 who attended antenatal clinics in 11 of the 15 countries analyzed. However, with 2.5 million children living with AIDS and most of them infected through mother-to-child transmission, this is merely a start.

While we have dramatically diminished mother-to-child transmission of HIV/AIDS in the United States, in the developing world most women still do not get the medicines that could keep them from transmitting HIV to their babies. That's a terrible failure. Without treatment, half the children infected with HIV/AIDS will die before their second birthday, and three in four will die before they turn five. With treatment, children can thrive and grow up healthy.

The Elizabeth Glaser Pediatric AIDS Foundation is working with ministries of health in the countries hardest hit by the pandemic to prevent transmission of HIV from mother to child and to treat children and families affected by HIV/AIDS. This new UNAIDS report shows that it's making a difference, but there's much more to do.

Right now, children account for almost 16 percent of all new HIV infections, but are just 9 percent of those receiving treatment through PEPFAR. That's why we are asking Congress to establish targets over the next five years to: give 80 percent of pregnant women services to prevent mother-to-child tran
'/>"/>

SOURCE Elizabeth Glaser Pediatric AIDS Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , NASHVILLE, Tenn., Dec. 1 /PRNewswire-F...aq: CPIX ) announced today that an independently ...jection, or intravenous N-acetylcysteine, as a cos... published in Volume 12, Number 4 of the peer-revi... in December. The study concludes that Acetadote i...
(Date:12/1/2009)..., CLEARWATER, Fla., Dec. 1 CCS ...r of medical supplies, today announced that it has...cy Court for District of Delaware (the "Court") fo...rketing and proposed sale of substantially all of ...ber 24, 2009, the Court approved bidding procedure...
(Date:12/1/2009)..., VIENNA, Va., Dec. 1 ...age oncology company and a developer of vaccines a...f infectious diseases, announced today that it has...t Research Organization (CRO) to run CEL-SCI,s upc... head and neck cancer with the Company,s lead prod...
Breaking Medicine Technology:Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3Canadian blood supply future uncertain as population ages 3A Study 59352 1Canadian blood supply future uncertain as population ages 3A Study 59352 2Long feared extinct rare bird rediscovered 10331 1Long feared extinct rare bird rediscovered 10331 2Many Americans Still Leery of Swine Flu Vaccine 59349 1Many Americans Still Leery of Swine Flu Vaccine 59349 2Many Americans Still Leery of Swine Flu Vaccine 59349 3
...er Journal , AUSTIN, Texas--(BUSINESS WIRE)--May 3... announced today the publication of,data describin...t,Advexin in a patient with a rare inherited form ...enetic disorder characterized by,inherited mutatio...irst reported treatment of Li-Fraumeni tumors with...
...0, 2007 - Rexahn,Pharmaceuticals, Inc. (OTC BB:RXH...iscovery, development, and commercialization of,in...stem disorders,sexual dysfunction and other unmet...hall, Principal Investigator of Phase I clinical,t... (Archexin),will present results of the clinical ...
Other Medicine Technology:Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4
(Date:12/2/2009)... 3D animation detailing plastic surg...ements website. Surgical candidates can view proce...y from the page. , (PRWEB... compression garments retailer, has always been de... patients after their procedures, providing liposu...
(Date:12/2/2009)... myEMRchoice.com Enables Personal He... Fort Washington, PA (PRWEB) Decemb...ive consumers is to read their own medical records...keeping control of personal medical records is eas... PA based healthcare technology company has added ...
(Date:12/2/2009)... Award-winning author James A. Feins...book, Short White Coat: Lessons from Patients on B...h the third year of medical school--the grueling c...HIA, PA (PRWEB) December 2, 2009 -- Most people w...ves dressed in a tiny hospital gown or staring at ...
(Date:12/2/2009)... Leading medical device software eng...s received ISO 13485 certification. A relatively f...firms have actually achieved ISO 13485 certificati...ification and adhere to other ISO standards as wel...ce software engineering consulting firm to achieve...
(Date:12/2/2009)..., SAN DIEGO, Dec. 2 Gen-...t the 21st Annual Piper Jaffray Health Care Confer...tion is scheduled to be webcast live and may be ac...Gen-Probe,s website at www.gen-probe.com . The we...event. ,, About Gen-Probe ,, Gen-Probe In...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2
...nd, March 6 Roche (SWX: ROG.VX; RO.S) announced t... outstanding publicly-held shares of Genentech (NY...e offer to 12:00 midnight, New York City time, on ...Based on conversations with Genentech shareholders...
...lif., March 6 On March 5, 2009, Santa Monica Medi...WS) ("SMMC"), a special purpose acquisition compan...d a preliminary proxy statement with the Securitie...cted to approve an extension to the time period du...
...ader Unveils New California Veggie Pockets, Tex Me...at Natural Products Expo West Conference , , ANAH...ds, the leader in sensible, heart-friendly frozen ...Veggie Pockets, Falafel Flats and Burrito Bites ...
...ven though more minorities than whites meet criter...March 6 (HealthDay News) -- When black and Hispani... they are less likely than their white counterpart...en racial and ethnic groups in the use of the most...
...uring the course of a hospitalization, patients ar...the physician who has primary responsibility for t...riate timing, inadequate details, illegibility, lo...e, M.D., of the Regenstrief Institute and colleagu...
...., March 6 Palomar Medical Technologies, Inc. (Na... of light-based systems for cosmetic treatments, a...s -- the XD Optic(TM), the GROOVE Optic(TM), LuxPo...tology (AAD) in San Francisco, California from Mar...
Other Medicine News:Health News:Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer 2Health News:Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer 3Health News:Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer 4Health News:Santa Monica Media Corporation Files Extension Proxy With SEC to Complete Transaction 2Health News:Dr. Praeger's Sensible Foods Launches Four New Frozen Food Products 2Health News:Dr. Praeger's Sensible Foods Launches Four New Frozen Food Products 3Health News:Blacks, Hispanics Less Apt to Get Best Heart Failure Care 2Health News:Blacks, Hispanics Less Apt to Get Best Heart Failure Care 3Health News:Giving doctors the complete picture 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 3Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 4Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 5Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 6
Liquichek Homocysteine Control
Liquichek D-dimer Control
Lyphochek Diabetes Control
Lyphochek Hemoglobin A2 Control
Medicine Products: